Dr. Hanssens Simon financials
A multi-period view of the public annual-account figures reported for Dr. Hanssens Simon, with comparable measures and links to available source documents.
Company overviewRegistry number
0721601905
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Dr. Hanssens Simon
2025 versus 2024
- Operating line
- €139,157
- EBITDA
- €136,893
- Total assets
- €224,551
- Equity
- €210,600
+1.3%
+0.6%
-4.8%
-5%
EBITDA margin +98.4% · Equity ratio +93.8%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Sept 2025 | €139,157 | €136,893 | €224,551 | €210,600 | - |
| 202430 Sept 2024 | €137,420 | €136,069 | €235,986 | €221,758 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.